Machine learning approach for the prediction of 30-day mortality in patients with sepsis-associated delirium

Xiaoli Shen1, Dongfeng Shang2, Weize Sun1

  • 1Department of Emergency Medicine, Huishan 3rd People's Hospital of Wuxi City, Wuxi, China.

Plos One
|April 9, 2025
PubMed

Insights

Machine learning models predict 30-day mortality in sepsis-associated delirium (SAD) patients. The Gradient Boosting Machine model showed the highest accuracy, aiding early identification of high-risk individuals.

Area of Science:

  • Critical Care Medicine
  • Medical Informatics
  • Computational Biology

Background:

  • Sepsis-associated delirium (SAD) is a critical condition with significant mortality.
  • Predicting 30-day mortality in SAD patients is crucial for timely intervention.
  • Existing prediction models may lack the precision required for personalized patient care.

Purpose of the Study:

  • To develop and validate machine learning (ML) models for predicting 30-day mortality in sepsis-associated delirium (SAD) patients.
  • To identify key independent predictors of mortality in SAD.
  • To compare the performance of various ML algorithms in predicting SAD mortality.

Main Methods:

  • Utilized a cohort of 3,197 SAD patients from the Medical Information Mart for Intensive Care (MIMIC)-IV database.
  • Employed Recursive Feature Elimination (RFE) to identify risk factors.
  • Developed and validated six ML models: NNET, GBM, Ada, RF, XGB, and LR, assessing performance via cross-validation and decision curve analysis.

Main Results:

  • Identified 10 independent predictors of 30-day mortality: GCS, SOFA, AG, CRRT, temperature, MCHC, vasopressor, BUN, BE, and bicarbonate.
  • All six ML models demonstrated favorable discrimination and calibration.
  • The Gradient Boosting Machine (GBM) model achieved the highest Area Under the Curve (AUC) of 0.845 (95% CI: 0.816, 0.874).

Conclusions:

  • Developed robust ML models for predicting 30-day mortality in SAD patients.
  • The GBM model offers superior predictive performance compared to other tested algorithms.
  • These models can assist clinicians in promptly identifying high-risk SAD patients for personalized management.

Related Concept Videos